Announcements
- KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
- KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
- KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
- KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
- KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- KALA BIO to Participate in Upcoming Investor Conferences in August
- Kala Pharmaceuticals Announces Name Change to KALA BIO
More ▼
Key statistics
On Friday, KALA BIO Inc (27F0:DUS) closed at 6.01, 27.60% above the 52 week low of 4.71 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.08 |
---|---|
High | 6.09 |
Low | 6.01 |
Bid | 6.02 |
Offer | 6.14 |
Previous close | 6.02 |
Average volume | 1.00 |
---|---|
Shares outstanding | 2.82m |
Free float | 2.49m |
P/E (TTM) | -- |
Market cap | 18.45m USD |
EPS (TTM) | -15.15 USD |
Data delayed at least 15 minutes, as of May 17 2024 18:30 BST.
More ▼